Cambridge Cognition Holdings (GB:COG) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cambridge Cognition Holdings has officially announced the resignation of Dr. Matthew Stork as Director, following his earlier step down as CEO. This change in leadership comes as the company continues to focus on its digital solutions for brain health, which play a crucial role in improving clinical trial outcomes and patient stratification globally.
For further insights into GB:COG stock, check out TipRanks’ Stock Analysis page.